Table: Delta-Fly Pharma - 6-MTH parent results

Delta-Fly Pharma

13/11/2023 06:05

Nov 13 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to   
                Sep 30, 2023        Sep 30, 2022       Mar 31, 2024  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
                                    (-100.0 pct)                     
  Operating     loss 593 mln        loss 611 mln        loss 1.31    
  Recurring     loss 599 mln        loss 620 mln        loss 1.32    
  Net           loss 600 mln        loss 622 mln        loss 1.32    
  EPS          loss 91.92 yen      loss 114.88 yen   loss 207.71 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T